Discussion on Immunization of Man Against Measles

Floyd Markham, Ph.D., Lederle Laboratories, Division American Cyanamid Company, Pearl River, N.Y.: It is evident from what has been presented so far at this meeting that we have in hand the means of doing a satisfactory job of controlling measles as a public health problem. There are various weapons available to us in making this attack or duel, whichever you choose to regard it. Regardless of which weapon we choose—the live virus by itself, the live virus with γ-globulin, killed vaccine, or a combination of killed vaccine and live vaccine—like the duelists, we are going to be targets. A study of our own experience, which in general is comparable in all respects to that which has been reported up to the present, indicates that there are some things that have not been brought out so far and which may be of interest. One of these is the relationship of the